What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...
Read More
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...
Read More
Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the...
Read More
Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with...
Read More
What do we know about plans and policy for 2024/25? As the expected central operating plan has not (yet) materialised, and with a general election and a potential Labour government...
Read More
What is health economic evaluation and which modelling approaches can be used to support market access activities? In this webinar, our expert health economists explain the key strengths and limitations...
Read More
In this live lecture, Hannah Baker (Consultant – Health Economics) outlines the role health economics plays in modern healthcare.
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice...
Read More
In this webinar, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or...
Read More
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst...
Read More
